2019
DOI: 10.1007/s10549-019-05376-9
|View full text |Cite
|
Sign up to set email alerts
|

PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 57 publications
1
14
0
Order By: Relevance
“…Moreover, alteration in metabolism by metformin may have increased the radiation‐mediated anticancer effects. A recently published paper supports our results that the triple‐negative breast cancer cells, MDA‐MB‐231 and SUM159PT, on treatment with 8 Gy radiation, showed increased glucose uptake and lactate production, suggesting that the re‐wiring of glucose metabolism may be necessary for cell survival and resistance to radiation 27 . Interestingly, we found that the treatment with adjuvant metformin and 10 Gy radiation increased the glucose uptake, but the degree of glucose uptake was less than that observed after treatment with radiation alone.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Moreover, alteration in metabolism by metformin may have increased the radiation‐mediated anticancer effects. A recently published paper supports our results that the triple‐negative breast cancer cells, MDA‐MB‐231 and SUM159PT, on treatment with 8 Gy radiation, showed increased glucose uptake and lactate production, suggesting that the re‐wiring of glucose metabolism may be necessary for cell survival and resistance to radiation 27 . Interestingly, we found that the treatment with adjuvant metformin and 10 Gy radiation increased the glucose uptake, but the degree of glucose uptake was less than that observed after treatment with radiation alone.…”
Section: Discussionsupporting
confidence: 87%
“…2.12 | 2-NDBG glucose uptake Glucose uptake was measured using a 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) glucose uptake assay kit (K682, BioVision) following a previous report. 27 MDA-MB-231(BR)-Luc cells were seeded in a 6 cm dish at a density of 2 Â 10 5 cells. Cells were treated with 5 mM metformin for 4 h, exposed to 10 Gy X-rays, and harvested after 24 h using trypsin-EDTA.…”
Section: Lactate Measurementmentioning
confidence: 99%
“…Although inhibition of hormone receptors, DNA damage repair, and immunomodulatory signaling represent the majority of the approaches to radiosensitization currently being studied in the clinic (Table 1), there are a number of other emerging preclinical radiosensitization strategies ( Abbreviations: DNAPK, DNA-dependent protein kinase; dsDNA, double-strand DNA; EGFR, epidermal growth factor receptor; ER, estrogen receptor; ERK, extracellular regulated kinase; HER2, human epidermal growth factor receptor 2; HR, homologous recombination; mTOR, mammalian target of rapamycin; TNBC, triple-negative breast cancer, VEGF, vascular endothelial growth factor. autophagy in, [149][150][151][152][153][154][155][156] or metabolic changes 157,158 usually thought to be minor contributing pathways to breast cancer radiosensitization, a number of these approaches likely have mixed mechanisms that lead to broad suppression of the DNA damage response, cell-cycle progression, or decreased hypoxia and HIF1a-related signaling. 127,[159][160][161][162][163][164][165][166][167] On-target and off-target effects of compounds designed to affect proliferation or cell-cell communication, such as the suppression of notch signaling 168 through gamma secretase inhibition 169 (Clinical-Trials.gov identifier: NCT01217411), can also be valuable approaches in the radiosensitization of breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The PGs ( n = 30) were collected from 2-day old females and then incubated in Graces' medium for 2 h. The medium was replaced by a new medium with PBAN (10 pM). PGs were collected at different time points of PBAN treatments (0, 10, 30, 60, and 90 min) and subjected to HaPYK activity analysis using the PYK activity kit from the Abcam company (Abcam, Cambridge, UK) following the instructions (Zhang et al, 2019 ). Three biological replicates were employed and every replicate contained at least 30 PGs.…”
Section: Methodsmentioning
confidence: 99%